Summary
Further key aspects of the report:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Multiple Sclerosis Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Multiple Sclerosis Drugs market segmented into
Oral
Injectable
Intravenous
Based on the end-use, the global Multiple Sclerosis Drugs market classified into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Based on geography, the global Multiple Sclerosis Drugs market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Biogen
Teva Pharmaceutical
Merck KGaA
Novartis
Bayer
Sanofi
Acorda Therapeutics
Questcor Pharmaceuticals
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL MULTIPLE SCLEROSIS DRUGS INDUSTRY
2.1 Summary about Multiple Sclerosis Drugs Industry
2.2 Multiple Sclerosis Drugs Market Trends
2.2.1 Multiple Sclerosis Drugs Production & Consumption Trends
2.2.2 Multiple Sclerosis Drugs Demand Structure Trends
2.3 Multiple Sclerosis Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Oral
4.2.2 Injectable
4.2.3 Intravenous
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital Pharmacy
4.3.2 Retail Pharmacy
4.3.3 Online Pharmacy
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Oral
5.2.2 Injectable
5.2.3 Intravenous
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital Pharmacy
5.3.2 Retail Pharmacy
5.3.3 Online Pharmacy
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Oral
6.2.2 Injectable
6.2.3 Intravenous
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital Pharmacy
6.3.2 Retail Pharmacy
6.3.3 Online Pharmacy
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Oral
7.2.2 Injectable
7.2.3 Intravenous
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital Pharmacy
7.3.2 Retail Pharmacy
7.3.3 Online Pharmacy
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Oral
8.2.2 Injectable
8.2.3 Intravenous
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital Pharmacy
8.3.2 Retail Pharmacy
8.3.3 Online Pharmacy
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Oral
9.2.2 Injectable
9.2.3 Intravenous
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital Pharmacy
9.3.2 Retail Pharmacy
9.3.3 Online Pharmacy
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Biogen
10.1.2 Teva Pharmaceutical
10.1.3 Merck KGaA
10.1.4 Novartis
10.1.5 Bayer
10.1.6 Sanofi
10.1.7 Acorda Therapeutics
10.1.8 Questcor Pharmaceuticals
10.2 Multiple Sclerosis Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Biogen
10.2.2 Teva Pharmaceutical
10.2.3 Merck KGaA
10.2.4 Novartis
10.2.5 Bayer
10.2.6 Sanofi
10.2.7 Acorda Therapeutics
10.2.8 Questcor Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Multiple Sclerosis Drugs Product Type Overview
Table Multiple Sclerosis Drugs Product Type Market Share List
Table Multiple Sclerosis Drugs Product Type of Major Players
Table Brief Introduction of Biogen
Table Brief Introduction of Teva Pharmaceutical
Table Brief Introduction of Merck KGaA
Table Brief Introduction of Novartis
Table Brief Introduction of Bayer
Table Brief Introduction of Sanofi
Table Brief Introduction of Acorda Therapeutics
Table Brief Introduction of Questcor Pharmaceuticals
Table Products & Services of Biogen
Table Products & Services of Teva Pharmaceutical
Table Products & Services of Merck KGaA
Table Products & Services of Novartis
Table Products & Services of Bayer
Table Products & Services of Sanofi
Table Products & Services of Acorda Therapeutics
Table Products & Services of Questcor Pharmaceuticals
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Multiple Sclerosis Drugs Market Forecast (Million USD) by Region 2021f-2026f
Table Global Multiple Sclerosis Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Multiple Sclerosis Drugs Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Multiple Sclerosis Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Multiple Sclerosis Drugs Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Multiple Sclerosis Drugs Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Multiple Sclerosis Drugs Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Multiple Sclerosis Drugs Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Multiple Sclerosis Drugs Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Multiple Sclerosis Drugs Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Multiple Sclerosis Drugs Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injectable Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Intravenous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injectable Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Intravenous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injectable Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Intravenous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injectable Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Intravenous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injectable Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Intravenous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injectable Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Intravenous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Multiple Sclerosis Drugs Sales Revenue (Million USD) of Biogen 2017-2020e
Figure Multiple Sclerosis Drugs Sales Revenue (Million USD) of Teva Pharmaceutical 2017-2020e
Figure Multiple Sclerosis Drugs Sales Revenue (Million USD) of Merck KGaA 2017-2020e
Figure Multiple Sclerosis Drugs Sales Revenue (Million USD) of Novartis 2017-2020e
Figure Multiple Sclerosis Drugs Sales Revenue (Million USD) of Bayer 2017-2020e
Figure Multiple Sclerosis Drugs Sales Revenue (Million USD) of Sanofi 2017-2020e
Figure Multiple Sclerosis Drugs Sales Revenue (Million USD) of Acorda Therapeutics 2017-2020e
Figure Multiple Sclerosis Drugs Sales Revenue (Million USD) of Questcor Pharmaceuticals 2017-2020e